AIMP1/p43 protein induces the maturation of bone marrow-derived dendritic cells with T helper type 1-polarizing ability

Journal of Immunology

Volumn 180, Issue 5, 2008, Pages 2894-2902

  Kim, Eugene ^a   Seung, Hyun Kim ^a   Kim, Sunghoon ^b   Cho, Daeho ^c   Tae, Sung Kim ^a  

^a Korea University   (South Korea)

^b Seoul National University   (South Korea)

^c Sookmyung Women's University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARS INTERACTING MULTIFUNCTIONAL PROTEIN 1; CD4 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 ANTIBODY; KEYHOLE LIMPET HEMOCYANIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEUTRALIZING ANTIBODY; PROTEIN P43; UNCLASSIFIED DRUG; AIMP1 PROTEIN, MOUSE; CYTOKINE; HLA ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PHENOTYPE; POLARIZATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CELL POLARITY; COCULTURE; CYTOLOGY; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SECRETION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL POLARITY; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERFERON TYPE II; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TH1 CELLS;

EID: 48749115388     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.5.2894     Document Type: Article

References (40)

1. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9: 271-296.
2. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
3. Dustin, M. L., and J. A. Cooper. 2000. The immunological synapse and the actin cytoskeleton: molecular hardware for T cell signaling. Nat. Immunol. 1: 23-29.
4. Lanzavecchia, A., and F. Sallusto. 2001. Antigen decoding by T lymphocytes: from synapses to fate determination. Nat. Immunol. 2: 487-492.
5. Gett, A. V., F. Sallusto, A. Lanzavecchia, and J. Geginat. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4: 355-360.
6. Curtsinger, J. M., D. C. Lins, and M. F. Mescher. 2003. Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J. Exp. Med. 197: 1141-1151.
7. Valenzuela, J., C. Schmidt, and M. Mescher. 2002. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J. Immunol. 169: 6842-6849.
8. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
9. Kalinski, P., C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. Immunol. Today 20: 561-567.
10. Sato, M., K. Iwakabe, S. Kimura, and T. Nishimura. 1999. Functional skewing of bone marrow-derived dendritic cells by Th1- or Th2-inducing cytokines. Immunol. Lett. 67: 63-68.
11. Quevillon, S., F. Agou, J. C. Robinson, and M. Mirande. 1997. The p43 component of the mammalian multi-synthetase complex is likely to be the precursor of the endothelial monocyte-activating polypeptide II cytokine. J. Biol. Chem. 272: 32573-32579.
12. Park, S. G., K. Ewalt, and S. Kim. 2005. Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on house-keepers. Trends Biochem. Sci. 30: 569-574.
13. Park, S. G., H. Shin, Y. K. Shin, Y. Lee, E. C. Choi, B. J. Park, and S. Kim. 2005. The novel cytokine p43 stimulates dermal fibroblast proliferation and wound repair. Am. J. Pathol. 166: 387-398.
14. Barnett, G., A. M. Jakobsen, M. Tas, K. Rice, J. Carmichael, and J. C. Murray. 2000. Prostate adenocarcinoma cells release the novel proinflammatory polypeptide EMAP-II in response to stress. Cancer Res. 60: 2850-2857.
15. Matschurat, S., U. E. Knies, V. Person, L. Fink, B. Stoelcker, C. Ebenebe, H. A. Behrensdorf, J. Schaper, and M. Clauss. 2003. Regulation of EMAP II by hypoxia. Am. J. Pathol. 162: 93-103.
16. Park, S. G., Y. S. Kang, Y. H. Ahn, S. H. Lee, K. R. Kim, K. W. Kim, G. Y. Koh, Y. G. Ko, and S. Kim. 2002. Dose-dependent biphasic activity of tRNA synthetase-associating factor, p43, in angiogenesis. J. Biol. Chem. 277: 45243-45248.
17. Ko, Y. G., H. Park, T. Kim, J. W. Lee, S. G. Park, W. Seol, J. E. Kim, W. H. Lee, S. H. Kim, J. E. Park, and S. Kim. 2001. A cofactor of tRNA synthertase, p43, is secreted to up-regulated proinflammatory genes. J. Biol. Chem. 276: 23028-23033.
18. Chang, S. Y., S. G. Park, S. Kim, and C. Y. Kang. 2002. Interaction of the C-terminal domain of p43 and the β subunit of ATP synthase: its functional implication in endothelial cell proliferation. J. Biol. Chem. 277: 8388-8394.
19. Park, H., S. G. Park, J. Kim, Y. G. Ko, and S. Kim. 2002. Signaling pathways for TNF production induced by human aminoacyl-tRNA synthetase- associating factor, p43. Cytokine 20: 148-153.
20. + T cells. J. Immunol. 176: 256-264.
21. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176: 1693-1702.
22. Kim, T. S., R. H. DeKruyff, R. Rupper, H. T. Maecker, S. Levy, and D. T. Umetsu. 1997. An ovalbumin-IL-12 fusion protein is more effective than ovalbumin plus free recombinant IL-12 in inducing a T helper cell type 1-dominated immune response and inhibiting antigen-specific IgE production. J. Immunol. 158: 4137-4144.
23. Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
24. Gallucci, S., M. Lolkema, and P. Matzinger. 1999. Natural adjuvants: endogenous activators of dendritic cells. Nat. Med. 5: 1249-1255.
25. de Jong, E. C., H. H. Smits, and M. L. Kapsenberg. 2005. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26: 289-307.
26. Czerniecki, B. J., G. K. Koski, U. Koldovsky, S. Xu, P. A. Cohen, R. Mick, H. Nisenbaum, T. Pasha, M. Xu, K. R. Fox, et al. 2007. Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer Res. 67: 1842-1852.
27. - DC. J. Immunol. 177: 7067-7075.
28. Hokey, D. A., A. T. Larregina, G. Erdos, S. C. Watkins, and L. D. Falo. Tumor cell loaded type-1 polarized dendritic cells induce Th1-mediated tumor immunity. Cancer Res. 65: 10059-10067.
29. + T cell responses in vitro. J. Immunother. 30: 75-82.
30. Watanabe, S., H. Kagamu, H. Yoshizawa, N. Fujita, H. Tanaka, J. Tanaka, and F. Gejyo. 2003. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity. J. Immunol. 171: 5828-5836.
31. Langenkamp, A., M. Messi, A. Lanzavecchia, and F. Sallusto. 2000. Kinetics of dendritic cell activation: impact on priming of Th1, Th2, and nonpolarized T cells. Nat. Immunol. 1: 311-316.
32. Kaliński, P., J. H. Schuitemaker, C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-γ and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 162: 3231-3236.
33. Boni, A., G. Iezzi, E. Degl'Innocenti, M. Grioni, E. Jachetti, A. Camporeale, and M. Bellone. 2006. Prolonged exposure of dendritic cells to maturation stimuli favors the induction of type-2 cytotoxic T lymphocytes. Eur. J. Immunol. 36: 3157-3166.
34. Kubo, M., T. Hanada, and A. Yoshimura. 2003. Suppressors of cytokine signaling and immunity. Nat. Immunol. 4: 1169-1176.
35. Jackson, S. H., C. R. Yu, R. M. Mahdi, S. Ebong, and C. E. Egwuagu. 2004. Dendritic cell maturation requires STAT1 and us under feedback regulation by suppressors of cytokine signaling. J. Immunol. 172: 2307-2315.
36. Evel-Kabler, K., X.-T. Song, M. Aldrich, X. F. Huang, and S.-Y. Chen. 2006. SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling. J. Clin. Invest. 116: 90-100.
37. Yi, J. S., J. Y. Lee, S. G. Chi, J. H. Kim, S. G. Park, S. Kim, and Y. G. Ko. 2005. Aminoacyl-tRNA synthetase-interacting multi-functional protein, p43, is imported to endothelial cells via lipid rafts. J. Cell. Biochem. 96: 1286-1295.
38. Hou, Y., P. A. Plett, D. A. Ingram, G. Rajashekhar, C. M. Orschell, M. C. Yoder, K. L. March, and M. Clauss. 2006. Endothelial-monocyte-activating polypeptide II induces migration of endothelial progenitor cells via the chemokine receptor CXCR3. Exp. Hematol. 34: 1125-1132.
39. Liu, L., M. K. Callahan, D. Huang, and R. M. Ransohoff. 2005. Chemokine receptor CXCR3: an unexpected enigma. Curr. Top. Dev. Biol. 68: 149-181.
40. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-683.